Inotiv Inc NOTV:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 4:04 PM EDT
18.40UNCH (UNCH)
Volume
4,951
Close
18.40quote price arrow up+0.58 (+3.25%)
Volume
182,069
52 week range
11.25 - 60.66
Loading...
  • Open17.71
  • Day High18.81
  • Day Low17.41
  • Prev Close17.82
  • 52 Week High60.66
  • 52 Week High Date11/19/21
  • 52 Week Low11.25
  • 52 Week Low Date05/12/22

Key Stats

  • Market Cap469.57M
  • Shares Out25.52M
  • 10 Day Average Volume0.43M
  • Dividend-
  • Dividend Yield-
  • Beta2.10
  • YTD % Change-56.26

KEY STATS

  • Open17.71
  • Day High18.81
  • Day Low17.41
  • Prev Close17.82
  • 52 Week High60.66
  • 52 Week High Date11/19/21
  • 52 Week Low11.25
  • 52 Week Low Date05/12/22
  • Market Cap469.57M
  • Shares Out25.52M
  • 10 Day Average Volume0.43M
  • Dividend-
  • Dividend Yield-
  • Beta2.10
  • YTD % Change-56.26

RATIOS/PROFITABILITY

  • EPS (TTM)-3.23
  • P/E (TTM)-5.70
  • Fwd P/E (NTM)-184.00
  • EBITDA (TTM)-10.904M
  • ROE (TTM)-23.14%
  • Revenue (TTM)277.49M
  • Gross Margin (TTM)29.55%
  • Net Margin (TTM)-26.39%
  • Debt To Equity (MRQ)54.67%

EVENTS

  • Earnings Date08/09/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Inotiv Inc

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Inotiv, Inc. is an international contract research company that is focused on providing drug discovery and development services and analytical instruments. The Company focuses on providing drug developers with scientific research and analytical instrumentation. The Company operates through two segments, including Contract Research Services and Research Products. The Contract Research Services segment provides screening and pharmacological testing, nonclinical safety testing...
Gregory Davis Ph.D.
Independent Chairman of the Board
Robert Leasure Jr.
President, Chief Executive Officer, Director
John Beattie
Chief Operating Officer
James Harkness
Chief Operating Officer - Research Models and Services
Beth Taylor
Chief Financial Officer, Vice President - Finance
Adrian Hardy Ph.D.
Executive Vice President
Mark Bibi
General Counsel, Secretary
Address
2701 Kent Ave
West Lafayette, IN
47906-1350
United States

Top Peers

SYMBOLLASTCHG%CHG
CNTG
Centogene NV
3.10+0.04+1.31%
DMTK
DermTech Inc
6.79+0.13+1.95%
TELA
TELA Bio Inc
8.85-0.14-1.56%
GTH
Genetron Holdings Ltd
1.45-0.08-5.23%
XGN
Exagen Inc
4.18-0.16-3.69%